학술논문

CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?
Document Type
Editorial
Source
Rheumatology. May2024, Vol. 63 Issue 5, p1192-1194. 3p.
Subject
*SYSTEMIC lupus erythematosus treatment
*T cells
*IMMUNOTHERAPY
*CELLULAR therapy
*TREATMENT effectiveness
*IMMUNOLOGIC receptors
Language
ISSN
1462-0324
Abstract
The article shares insight on the application of chimeric antigen receptor (CAR)-T cell therapy in systemic lupus erythematosus (SLE) and other autoimmune rheumatic diseases. It cites results of clinical trials which demonstrated the efficacy and beneficial effects of CD19-targeting CAR T-cell therapy in autoimmunity, including in severe refractory SLE, cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.